Skip to content

PCR, qPCR, dPCR, and ddPCR

TL;DR

PCR amplifies a target DNA region. qPCR measures amplification in real time and is often used for relative abundance. dPCR/ddPCR partitions a sample into many reactions and estimates absolute copy number by counting positive partitions. These methods are fast and sensitive, but only answer questions about targets you designed primers/probes for. Sources: [1], [2]


What it measures

MethodMeasuresTypical oncology use
PCRpresence/size of an ampliconclonality check, construct verification
RT-PCRRNA converted to cDNAfusion transcript or viral transcript detection
qPCRrelative or calibrated abundancegene expression, copy-number estimate
dPCR / ddPCRabsolute copies or allele fractionlow-frequency mutation, MRD-like monitoring, CNV

What it does not measure

  • unknown mutations outside the designed assay
  • genome-wide context
  • transcript isoforms unless specifically designed
  • protein abundance
  • cell identity
  • tissue location

If you do not know what target to ask for, sequencing is usually the better first tool.


Core QC questions

  • Are primer/probe sequences documented?
  • Is the amplicon specific?
  • Are no-template and no-RT controls clean?
  • Is RNA integrity acceptable for RT-qPCR?
  • Are reference genes stable in this sample type?
  • Is amplification efficiency measured?
  • For dPCR, are partitions numerous and rain/thresholding handled consistently?

Computational output

Raw outputDownstream interpretation
Ct/Cqlower value usually means more starting template
melt curvespecificity check for dye-based assays
droplet/partition countsabsolute copies after Poisson correction
standard curvequantification and efficiency estimate

Developer notes

  • Store primer/probe IDs as structured metadata, not free text.
  • Keep raw Ct/Cq values; do not only store normalized fold change.
  • Track failed wells and excluded replicates explicitly.
  • Record reference genes and normalization method.
  • For ddPCR, keep thresholding rules and droplet counts, not just final concentration.
  • Never compare qPCR runs without batch, plate, and efficiency context.

References

  1. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611-622. PMID 19246619. https://doi.org/10.1373/clinchem.2008.112797
  2. Bustin SA, Benes V, Garson JA, et al. MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments Guidelines. Clin Chem 2025. PMID 40272429. https://doi.org/10.1093/clinchem/hvaf043

Early public release. Content evolves through continuous review. Questions: [email protected] · CC BY 4.0 where applicable.